Edison Investment Research - Pharmaceuticals & healthcare - ReNeuron Group: Building on last year's business development activities, ReNeuron has announced its first collaboration based on its exosome platform which was introduced at its 2018 capital markets day. At that time, the whole exosome field was at an early research stage but ReNeuron's collaboration with a US-based biopharmaceutical company marks the fourth and latest in a series of exosome deals announced in the sector in less than a year.
ISIN: GB00BF5G6K95Den vollständigen Artikel lesen ...
ISIN: GB00BF5G6K95Den vollständigen Artikel lesen ...
© 2019 Edison Investment Research